Skip to main content

Activator Protein-1 Transcription Factors in Pathological Cancers

  • Chapter
  • First Online:
Role of Transcription Factors in Gastrointestinal Malignancies

Abstract

Activator protein-1 transcription factors play a critical role in the development of many cancers. Although many studies indicated the role of transcription factors driving the progression of cancer, there is still a knowledge gap in the process of better understanding the molecular mechanisms controlled by AP-1 transcription factors during cancer advancement. In conclusion, we have evaluated the role of transcription factors which provides new insights into mechanisms of regulation of colorectal cancer by AP-1 family transcription factors.

The original version of this chapter was revised. The book was inadvertently published without Abstracts and Keywords, which are now included in all the chapters. An erratum to this chapter can be found at https://doi.org/10.1007/978-981-10-6728-0_39

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

%:

Percent

AP-1:

Activator protein-1

ATF:

Activating transcription factor

CRC:

Colorectal cancer

MAF:

Musculoaponeurotic liposarcoma

TPA:

12-O-tetradecanoylphorbol-13-acetate

TRE:

TPA-response element

References

  1. Ambartsumian NS, Grigorian MS, Larsen IF, Karlstrom O, Sidenius N, Rygaard J et al (1996) Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Oncogene 13:1621–1630

    PubMed  CAS  Google Scholar 

  2. Andersen H, Mahmood S, Tkach V, Cohn M, Kustikova O, Grigorian M et al (2002) The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials. Oncogene 21:4843–4848

    Article  CAS  PubMed  Google Scholar 

  3. Andersen H, Mejlvang J, Mahmood S, Gromova I, Gromov P, Lukanidin E et al (2005) Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Mol Cell Biol 25:9138–9150

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochem Biophys Acta 1072:129–157

    PubMed  CAS  Google Scholar 

  5. Bostick RM, Potter JD, Kushi LH, Sellers TA, Steinmetz KA, McKenzie DR et al (1994) Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5:38–52

    Article  CAS  Google Scholar 

  6. Bracke ME, Depypere H, Labit C, Van Marck V, Vennekens K, Vermeulen SJ et al (1997) Functional downregulation of the E-cadherin/catenin complex leads to loss of contact inhibition of motility and of mitochondrial activity, but not of growth in confluent epithelial cell cultures. Eur J Cell Biol 74:342–349

    PubMed  CAS  Google Scholar 

  7. Chiappetta G, Tallini G, De Biasio MC, Pentimalli F, de Nigris F, Losito S et al (2000) FRA-1 expression in hyperplastic and neoplastic thyroid diseases. Clin Cancer Res 6:4300–4306

    PubMed  CAS  Google Scholar 

  8. Colbert LH, Hartman TJ, Malila N, Limburg PJ, Pietinen P, Virtamo J et al (2001) Physical activity in relation to cancer of the colon and rectum in a cohort of male smokers. Cancer Epidemiol Biomark Prev 10:265–268

    CAS  Google Scholar 

  9. Colditz GA, Cannuscio CC, Frazier AL (1997) Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control 8:649–667

    Article  CAS  PubMed  Google Scholar 

  10. Croce CM (2008) Oncogenes and cancer. N Engl J Med 358:502–511

    Article  CAS  PubMed  Google Scholar 

  11. Dailey UG (1922) Cancer, facts and figures about. J Natl Med Assoc 14:7–9

    PubMed  PubMed Central  CAS  Google Scholar 

  12. Duesberg PH, Vogt PK (1970) Differences between the ribonucleic acids of transforming and nontransforming avian tumor viruses. Proc Natl Acad Sci U S A 67:1673–1680

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3:859–868

    Article  CAS  PubMed  Google Scholar 

  14. Gill G (2001) Regulation of the initiation of eukaryotic transcription. Essays Biochem 37:33–43

    Article  CAS  PubMed  Google Scholar 

  15. Giovannucci E (2004) Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J Nutr 134:2475S–2481S

    Article  CAS  PubMed  Google Scholar 

  16. Giovannucci E, Willett WC (1994) Dietary factors and risk of colon cancer. Ann Med 26:443–452

    Article  CAS  PubMed  Google Scholar 

  17. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93–99

    Article  CAS  Google Scholar 

  18. Handschuh G, Candidus S, Luber B, Reich U, Schott C, Oswald S et al (1999) Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 18:4301–4312

    Article  CAS  PubMed  Google Scholar 

  19. Heldin CH, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283–1316

    Article  CAS  PubMed  Google Scholar 

  20. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB et al (1999) Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91:542–547

    Article  CAS  PubMed  Google Scholar 

  21. Hu YC, Lam KY, Law S, Wong J, Srivastava G (2001) Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 7:2213–2221

    PubMed  CAS  Google Scholar 

  22. Huebner K, Croce CM (2001) FRA3B and other common fragile sites: the weakest links. Nat Rev Cancer 1:214–221

    Article  CAS  PubMed  Google Scholar 

  23. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66

    Article  PubMed  Google Scholar 

  24. Jochum W, Passegue E, Wagner EF (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20:2401–2412

    Article  CAS  Google Scholar 

  25. Konopka JB, Watanabe SM, Singer JW, Collins SJ, Witte ON (1985) Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proc Natl Acad Sci U S A 82:1810–1814

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Kustikova O, Kramerov D, Grigorian M, Berezin V, Bock E, Lukanidin E et al (1998) Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol 18:7095–7105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. La Vecchia C, Negri E, Decarli A, Franceschi S (1997) Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomark Prev 6:1007–1010

    Google Scholar 

  28. Larsson SC, Giovannucci E, Wolk A (2005) Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care 28:1805–1807

    Article  PubMed  Google Scholar 

  29. Limburg PJ, Anderson KE, Johnson TW, Jacobs DR Jr, Lazovich D, Hong CP et al (2005) Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women’s Health Study. Cancer Epidemiol Biomark Prev 14:133–137

    Google Scholar 

  30. Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK et al (2006) Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol 101:1872–1879

    Article  PubMed  Google Scholar 

  31. Lukashev ME, Werb Z (1998) ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8:437–441

    Article  CAS  PubMed  Google Scholar 

  32. Mareel M, Leroy A (2003) Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83:337–376

    Article  CAS  PubMed  Google Scholar 

  33. Mareel MM, Van Roy FM (1986) Are oncogenes involved in invasion and metastasis? Anticancer Res 6:419–435

    PubMed  CAS  Google Scholar 

  34. Mottram JC (1994) cdc2-related protein kinases and cell cycle control in trypanosomatids. Parasitol Today 10:253–257

    Article  CAS  PubMed  Google Scholar 

  35. Norat T, Bingham S, Ferrari P, Slimani N, Jenab M, Mazuir M et al (2005) Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 97:906–916

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J et al (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587–597

    Article  CAS  PubMed  Google Scholar 

  37. Pappou EP, Ahuja N (2010) The role of oncogenes in gastrointestinal cancer. Gastrointest Cancer Res: (Suppl 1):S2–S15

    Google Scholar 

  38. Rous P (1910) A transmissible avian neoplasm. (Sarcoma of the common fowl). J Exp Med 12:696–705

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Rous P (1911) A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13:397–411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Schlech WF 3rd (2000) Foodborne listeriosis. Clin Infect Dis 31:770–775

    Article  PubMed  Google Scholar 

  41. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131–E136

    Article  CAS  PubMed  Google Scholar 

  42. Shtivelman E, Lifshitz B, Gale RP, Canaani E (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315:550–554

    Article  CAS  Google Scholar 

  43. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405–1410

    Article  CAS  PubMed  Google Scholar 

  44. Stehelin D, Varmus HE, Bishop JM, Vogt PK (1976) DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260:170–173

    Article  CAS  PubMed  Google Scholar 

  45. Temin HM, Rubin H (1958) Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology 6:669–688

    Article  CAS  PubMed  Google Scholar 

  46. Tkach V, Tulchinsky E, Lukanidin E, Vinson C, Bock E, Berezin V (2003) Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility. Oncogene 22:5045–5054

    Article  CAS  PubMed  Google Scholar 

  47. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM (1985) The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390–1393

    Article  CAS  Google Scholar 

  48. van Duijnhoven FJ, Bueno-De-Mesquita HB, Ferrari P, Jenab M, Boshuizen HC, Ros MM et al (2009) Fruit, vegetables, and colorectal cancer risk: the European prospective investigation into cancer and nutrition. Am J Clin Nutr 89:1441–1452

    Article  PubMed  Google Scholar 

  49. Van Hoorde L, Van Aken E, Mareel M (2000) Collagen type I: a substrate and a signal for invasion. Prog Mol Subcell Biol 25:105–134

    Article  PubMed  Google Scholar 

  50. van Nimwegen E (2003) Scaling laws in the functional content of genomes. Trends Genet 19:479–484

    Article  CAS  PubMed  Google Scholar 

  51. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R et al (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5:793–802

    Article  CAS  PubMed  Google Scholar 

  52. Wagner EF, Matsuo K (2003) Signalling in osteoclasts and the role of Fos/AP1 proteins. Ann Rheum Dis 62(Suppl 2):ii83–ii85

    PubMed  PubMed Central  CAS  Google Scholar 

  53. Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM (1984) The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199:502–508

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Wang HL, Wang J, Xiao SY, Haydon R, Stoiber D, He TC et al (2002) Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer 101:301–310

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Santoshi Muppala .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Nature Singapore Pte Ltd

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Konduru, S.K.P., Prasad, G.L.V., Merchant, N., Muppala, S. (2017). Activator Protein-1 Transcription Factors in Pathological Cancers. In: Nagaraju, G., Bramhachari, P. (eds) Role of Transcription Factors in Gastrointestinal Malignancies. Springer, Singapore. https://doi.org/10.1007/978-981-10-6728-0_16

Download citation

Publish with us

Policies and ethics